Next Article in Journal
A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC)
Next Article in Special Issue
Poly ε-Caprolactone Nanoparticles for Sustained Intra-Articular Immune Modulation in Adjuvant-Induced Arthritis Rodent Model
Previous Article in Journal
Development and Optimization of Nanolipid-Based Formulation of Diclofenac Sodium: In Vitro Characterization and Preclinical Evaluation
Previous Article in Special Issue
Enhancement of the Solubility and Bioavailability of Pitavastatin through a Self-Nanoemulsifying Drug Delivery System (SNEDDS)
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(3), 510; https://doi.org/10.3390/pharmaceutics14030510
Action Date Notes Link
article xml file uploaded 25 February 2022 13:31 CET Original file -
article xml uploaded. 25 February 2022 13:31 CET Update https://www.mdpi.com/1999-4923/14/3/510/xml
article pdf uploaded. 25 February 2022 13:31 CET Version of Record https://www.mdpi.com/1999-4923/14/3/510/pdf
article html file updated 25 February 2022 13:33 CET Original file -
article html file updated 1 August 2022 02:48 CEST Update https://www.mdpi.com/1999-4923/14/3/510/html
Back to TopTop